Prothrombotic factors, endothelial function and left ventricular hypertrophy in isolated systolic hypertension

G Y Lip1, A D Blann, D G Beevers

  • 1University Department of Medicine, City Hospital, Birmingham, UK. g.y.h.lip@bham.ac.uk

Journal of Hypertension
|August 31, 1999
PubMed

Insights

Individuals with isolated systolic hypertension (ISH) show similar blood clotting and endothelial dysfunction markers as those with systolic-diastolic hypertension (SDH). This suggests ISH also increases the risk of thrombotic events like stroke and heart attack.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Hypertension Research

Background:

  • Systolic-diastolic hypertension (SDH) increases thrombotic complication risk.
  • Isolated systolic hypertension (ISH) also presents significant cardiovascular risk.
  • ISH may involve a prothrombotic state similar to SDH.

Purpose of the Study:

  • To investigate if ISH patients exhibit a prothrombotic state comparable to SDH patients.
  • To compare echocardiographic parameters between ISH and SDH patients.

Main Methods:

  • Measured hemorheology, endothelial dysfunction, thrombogenesis, and platelet activation in ISH, SDH, and control groups.
  • Compared echocardiographic parameters between ISH and SDH patients.

Main Results:

  • Plasma viscosity, von Willebrand factor, plasminogen activator inhibitor-1, and lipoprotein(a) were elevated in ISH and SDH versus controls.
  • SDH patients showed higher plasma fibrinogen and hematocrit than controls.
  • Echocardiographic parameters were similar between ISH and SDH patients.

Conclusions:

  • Individuals with ISH demonstrate prothrombotic factor and endothelial dysfunction abnormalities similar to SDH.
  • Echocardiographic parameters in ISH are comparable to those in SDH.
  • These findings support the increased risk of thrombotic events in ISH patients.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...